Clinical and laboratory characterization of a large cohort of patients with Castleman disease retrospectively collected from a single center

被引:22
作者
Dong, Yujun [1 ]
Na, Jia [2 ]
Lv, Jicheng [3 ]
Wang, Rengui [4 ]
Chen, Xixue [5 ]
Li, Nan [6 ]
Ren, Hanyun [1 ]
机构
[1] Peking Univ, Hosp 1, Dept Hematol, Beijing 100034, Peoples R China
[2] Peking Univ, Hosp 1, Dept Pathol, Beijing 100034, Peoples R China
[3] Peking Univ, Hosp 1, Dept Nephrol, Beijing 100034, Peoples R China
[4] Peking Univ, Hosp 1, Dept Med Imaging, Beijing 100034, Peoples R China
[5] Peking Univ, Hosp 1, Dept Dermatol, Beijing 100034, Peoples R China
[6] Peking Univ, Hosp 1, Dept Respirat, Beijing 100034, Peoples R China
基金
中国国家自然科学基金;
关键词
Cytokine production and paraneoplastic conditions; prognostication; morphology; AUTOIMMUNE HEMOLYTIC-ANEMIA; LYMPH-NODE HYPERPLASIA; OF-THE-LITERATURE; PARANEOPLASTIC PEMPHIGUS; SYSTEMIC MANIFESTATIONS; NEPHROTIC SYNDROME; ANTIBODY THERAPY; GLOMERULONEPHRITIS; THALIDOMIDE; REMISSION;
D O I
10.1080/10428190903060095
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The clinical, pathological treatment, and prognostic data of 55 patients with Castleman disease ( CD) were collected retrospectively from a single medical center. Thirty-four cases were classified as uni-centric; the remaining 21 cases were diagnosed as multi-centric CD. Regarding pathological classification, 38 cases were hyaline vascular type, account for 69.1% of all patients. Nine cases were diagnosed as plasmacytic type and eight cases as mixed cellularity type. Several prominent clinical complications were noted in this group of patients with CD: the skin, internal organs, and hematopoietic system were involved individually or concurrently. Clinical complications were distinct between different clinical and pathological subtypes of CD. The unique clinical and laboratory features of patients with paraneoplastic pemphigus suggests this diagnosis should be characterized as an independent disease entity. The presence of clinical complications is an independent prognostic factor in all patients with CD. More effective initial therapy should be considered in patients with CD with complications to improve the overall survival.
引用
收藏
页码:1308 / 1317
页数:10
相关论文
共 41 条
[1]   PARANEOPLASTIC PEMPHIGUS - AN AUTOIMMUNE MUCOCUTANEOUS DISEASE ASSOCIATED WITH NEOPLASIA [J].
ANHALT, GJ ;
KIM, S ;
STANLEY, JR ;
KORMAN, NJ ;
JABS, DA ;
KORY, M ;
IZUMI, H ;
RATRIE, H ;
MUTASIM, D ;
ARISSABDO, L ;
LABIB, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (25) :1729-1735
[2]   ALLEVIATION OF SYSTEMIC MANIFESTATIONS OF CASTLEMANS DISEASE BY MONOCLONAL ANTI-INTERLEUKIN-6 ANTIBODY [J].
BECK, JT ;
HSU, SM ;
WIJDENES, J ;
BATAILLE, R ;
KLEIN, B ;
VESOLE, D ;
HAYDEN, K ;
JAGANNATH, S ;
BARLOGIE, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (09) :602-605
[3]  
Bowne WB, 1999, CANCER, V85, P706, DOI 10.1002/(SICI)1097-0142(19990201)85:3<706::AID-CNCR21>3.0.CO
[4]  
2-7
[5]   The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care [J].
Casper, C .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (01) :3-17
[6]  
CASTLEMAN B, 1956, CANCER-AM CANCER SOC, V9, P822, DOI 10.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO
[7]  
2-4
[8]   IDENTIFICATION OF HERPESVIRUS-LIKE DNA-SEQUENCES IN AIDS-ASSOCIATED KAPOSIS-SARCOMA [J].
CHANG, Y ;
CESARMAN, E ;
PESSIN, MS ;
LEE, F ;
CULPEPPER, J ;
KNOWLES, DM ;
MOORE, PS .
SCIENCE, 1994, 266 (5192) :1865-1869
[9]   Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy [J].
Corbellino, M ;
Bestetti, G ;
Scalamogna, C ;
Calattini, S ;
Galazzi, M ;
Meroni, L ;
Manganaro, D ;
Fasan, M ;
Moroni, M ;
Galli, M ;
Parravicini, C .
BLOOD, 2001, 98 (12) :3473-3475
[10]   Chronic lymphocytic leukemia-associated autoimmune hemolytic anemia [J].
D'Arena, Giovanni ;
Cascavilla, Nicola .
LEUKEMIA & LYMPHOMA, 2007, 48 (06) :1072-1080